BioSpace News Archive

Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune diseases, is pleased to announce that one of its drugs produced strong effects in modulating gut microbiota in a mouse model study of inflammatory bowel disease.

Galderma Laboratories, L.P. and AKLIEF® (trifarotene) Cream, 0.005%, announced the launch of Me Being Me, a new consumer campaign, crafted in response to today’s increasingly digital-focused world, aimed to shed light on the powerful connection between acne and self-confidence impacting many teens and young adults

Saint-Gobain Life Sciences, an industry leader in material science-based solutions for cell and gene therapy manufacturing, today launched a new cell culture bag designed specifically for T cell derived therapies.

Elekta announced that several cancer centers are the early adopters of the company’s first release in the MOSAIQ® 3* series.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer’s disease.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced financial results for the fourth quarter and full year ended December 31, 2020.

Results from the pivotal Phase 2 KarMMa study evaluating the efficacy and safety of bluebird bio, Inc. (Nasdaq: BLUE) and Bristol Myers Squibb’s (NYSE: BMY) investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy, idecabtagene vicleucel (ide-cel; bb2121), i

Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests.

World’s largest AIDS group urges administration to also deploy Ryan White clinics as vaccination sites to better reach ambitious and lifesaving target

The Alzheimer’s Drug Discovery Foundation, a leading nonprofit solely focused on accelerating the development of drugs for Alzheimer’s disease and related dementias, announced a significant expansion of its leadership team with the hiring of Karen Bettauer Harris as chief financial officer and Dr. Mark S. Forman as senior director of drug development.